SCHEMBL19106396

SCHEMBL19106396

c1ccc(-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)nc3sc4ccccc4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.39
▸ MEN1 O00255 5/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HPGD P15428 6/20 0.36
▸ ADORA2A P29274 6/20 0.36
▸ ADORA1 P30542 5/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MPI P34949 1/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106415 0.93 CYP11B1 (0.36) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL19106447 0.93 CYP11B1 (0.37) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL19106438 0.92 CYP11B1 (0.36) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL19106462 0.91 CYP11B1 (0.37) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL18370860 0.91 CYP11B1 (0.37) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL24280181 0.91 MEN1 (0.39) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL19106449 0.90 CYP11B1 (0.35) CYP11B1MEN1KMT2AATMHPGD
SCHEMBL19106465 0.89 CYP11B1 (0.36) CYP11B1MEN1KMT2AHPGDADORA2A
SCHEMBL19106458 0.89 CYP11B1 (0.36) CYP11B1MEN1KMT2AHPGDADORA2A
SCHEMBL18017822 0.88 MEN1 (0.45) MEN1KMT2AATMHPGDADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 CYP11B1 1948/4885MEN1 1003/4885KMT2A 581/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 CYP11B1 1948/4885MEN1 1003/4885KMT2A 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback